• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec10
Barclays Upgrades Organon & Co. Rating to 'Strong Sell'
12:58
Nov25
Organon & Co. to Attend Piper Sandler Healthcare Conference
12:30
Nov17
FDA Approves Organon and Fosun Henlius' POHERDY as First Perjeta Biosimilar in the US
10:30
Nov13
Organon & Co's Executive Chair Carrie Smith Cox Acquires Shares
21:06
Nov11
U.S. Bank Securities and Piper Sandler Maintain Sell Ratings for Organon
11:42
Nov10
Organon released FY2025 Q3 earnings on November 10 Pre-Market EST, actual revenue USD 1.602 B (forecast USD 1.575 B), actual EPS USD 0.61
14:30

Schedules & Filings

Schedules
Filings
Dec11
Distribution Plan(EST)

Cash dividend 0.02 USD

Nov20
Distribution Plan(EST)

Cash dividend 0.02 USD

Distribution Plan(EST)

Cash dividend 0.02 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More